Melanoma Archives - Express Pharma

Shorter immunotherapy duration for advanced melanoma shows comparable disease control in UK DANTE trial

USFDA approves injectable version of Bristol Myers Squibb’s Opdivo

Merck discontinues Phase 3 KeyVibe-010 trial

Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028: GlobalData

Merck and Moderna initiate phase 3 study evaluating V940

Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma

Scientists double understanding of genetic risk of melanoma

Researchers develop effective nano-vaccine for melanoma

Melanoma treatment market value to more than quadruple to $5.64 bn by 2023: GlobalData